BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11920805)

  • 1. High-dose oral ganciclovir for management of CMV-symptomatic infection in a child with acute lymphoblastic leukemia.
    Castagnola E; Cristina E; Dufour C
    Med Pediatr Oncol; 2002 Apr; 38(4):295-6. PubMed ID: 11920805
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral ganciclovir.
    Schouten JT
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus pneumonia in adult acute lymphoblastic leukemia.
    Malhotra P; Menon MC; Varma N; Mishra B; Saikia UN; Suri V; Varma S
    J Assoc Physicians India; 2008 Jul; 56():541-2. PubMed ID: 18846908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic uremic syndrome in a child with leukemia and cytomegalovirus infection.
    Cavagnaro F; Barriga F
    Pediatr Nephrol; 2000 Oct; 14(12):1118-20. PubMed ID: 11045399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus Retinitis in Three Pediatric Cases with Acute Lymphoblastic Leukemia: Case Series and Review of the Literature.
    Demir SÖ; Çeliker H; Karaaslan A; Kadayifci EK; Akkoç G; Atıcı S; Yakut N; Şenay E; Kazokoğlu H; Koç A; Bakır M; Soysal A
    Jpn J Infect Dis; 2016 Nov; 69(6):534-538. PubMed ID: 26567834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ganciclovir: review and specific treatment of systemic cytomegalovirus infection in a leukemic child].
    Lasarte Iradi JR; Navajas Gutiérrez A; Astigarraga Aguirre I; Rubio Fernández G; Moya Calderón E; Bezanilla Regato JL
    An Esp Pediatr; 1991 May; 34(5):401-3. PubMed ID: 1652908
    [No Abstract]   [Full Text] [Related]  

  • 7. CMV drug approved.
    Treat Rev; 1995 Nov; (no 20):5. PubMed ID: 11363026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
    Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
    Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study.
    Sagedal S; Nordal KP; Hartmann A; Midtvedt K; Foss A; Asberg A; Degré M; Fauchald P; Rollag H
    Nephrol Dial Transplant; 2003 Sep; 18(9):1899-908. PubMed ID: 12937241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of children with congenital cytomegalovirus infection with ganciclovir.
    Michaels MG; Greenberg DP; Sabo DL; Wald ER
    Pediatr Infect Dis J; 2003 Jun; 22(6):504-9. PubMed ID: 12799506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.
    Stockmann C; Roberts JK; Knackstedt ED; Spigarelli MG; Sherwin CM
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):205-19. PubMed ID: 25428442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA approves oral ganciclovir as first drug to prevent CMV disease. Food and Drug Administration.
    Baker R
    BETA; 1995 Dec; ():8. PubMed ID: 11363015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment?
    Rayes N; Seehofer D; Schmidt CA; Müller AR; Steinmüller T; Bechstein WO; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1804. PubMed ID: 11267520
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute cholestatic hepatitis by cytomegalovirus in an immunocompetent patient resolved with ganciclovir.
    Serna-Higuera C; González-García M; Milicua JM; Muñoz V
    J Clin Gastroenterol; 1999 Oct; 29(3):276-7. PubMed ID: 10509956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Different dosages Ganciclovir treatment of symptomatic congenital cytomegalovirus infection in neonatal].
    Hong-Bin Z; Feng-Xian Z; Cai-Ping G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):57-9. PubMed ID: 22919757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful oral ganciclovir as maintenance therapy in an acquired immune deficiency syndrome (AIDS) patient with cytomegalovirus (CMV) induced perforative colitis].
    Mihara H; Suganuma K; Imai N; Hattori A; Watarai M; Satoh A; Imamura A; Miwa H; Kato Y; Nitta M
    Nihon Naika Gakkai Zasshi; 2005 Dec; 94(12):2606-8. PubMed ID: 16419603
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytomegalovirus epithelitis in an immunocompromised patient of T-cell acute lymphoblastic leukemia.
    Agashe P; Seth S; Doshi A
    Indian J Ophthalmol; 2020 Oct; 68(10):2216-2217. PubMed ID: 32971647
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral valganciclovir for colonic dilatation in ulcerative colitis associated with human cytomegalovirus infection.
    Criscuoli V; Plano S; Aragona E; Cottone M
    Inflamm Bowel Dis; 2010 May; 16(5):727-8. PubMed ID: 19714761
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment and prophylaxis of cytomegalovirus disease.
    Levinson ML; Jacobson PA
    Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.